These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6473092)

  • 1. Structure of heparins and their fragments.
    Casu B
    Nouv Rev Fr Hematol (1978); 1984; 26(4):211-9. PubMed ID: 6473092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of heparins and heterogeneity of low molecular weight heparins.
    Bianchini P; Liverani L; Spelta F; Mascellani G; Parma B
    Semin Thromb Hemost; 2007 Jul; 33(5):496-502. PubMed ID: 17629846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Supersulfated" heparin fragments, a new type of low-molecular weight heparin. Physico-chemical and pharmacological properties.
    Naggi A; Torri G; Casu B; Pangrazzi J; Abbadini M; Zametta M; Donati MB; Lansen J; Maffrand JP
    Biochem Pharmacol; 1987 Jun; 36(12):1895-900. PubMed ID: 3593400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative activities of heparin fractions obtained by gel chromatography.
    Graham DT; Pomeroy AR
    Thromb Haemost; 1980 Feb; 42(5):1598-603. PubMed ID: 7368160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic actions and pharmacokinetics of heparin fractions and fragments.
    Fareed J; Kumar A; Walenga JM; Emanuele RM; Williamson K; Hoppensteadt D
    Nouv Rev Fr Hematol (1978); 1984; 26(4):267-75. PubMed ID: 6473096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The heparins: structure and pharmacology].
    Choay J
    Rev Prat; 1988 May; 38(15):917-24. PubMed ID: 2839891
    [No Abstract]   [Full Text] [Related]  

  • 7. Production and chemical processing of low molecular weight heparins.
    Linhardt RJ; Gunay NS
    Semin Thromb Hemost; 1999; 25 Suppl 3():5-16. PubMed ID: 10549711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New data on heparin (a review)].
    Bychkov SM
    Vopr Med Khim; 1981; 27(6):726-36. PubMed ID: 7039095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heparins of different molecular weights: biological activity and hemorrhagic risk].
    Cofrancesco E; Pogliani EM
    Recenti Prog Med; 1987; 78(7-8):328-31. PubMed ID: 3321255
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods in heparin depolymerization: oligo-heteropolysaccharides as antithrombotic agents. New frontiers in prophylaxis of venous thrombosis.
    Fussi F; Ceppi G
    Boll Chim Farm; 1986 Sep; 125(9):339-45. PubMed ID: 3828100
    [No Abstract]   [Full Text] [Related]  

  • 11. Free radical generation during chemical depolymerization of heparin.
    Rota C; Liverani L; Spelta F; Mascellani G; Tomasi A; Iannone A; Vismara E
    Anal Biochem; 2005 Sep; 344(2):193-203. PubMed ID: 16098471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of unfractionated heparin and low molecular weight heparins in rabbit plasma--the need for using absolute anti-factor Xa and antithrombin activities.
    Peyrou V; Béguin S; Boneu B; Hemker HC
    Thromb Haemost; 1997 Feb; 77(2):312-6. PubMed ID: 9157588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P; Osima B; Parma B; Nader HB; Dietrich CP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):406-10. PubMed ID: 7057400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gel permeation chromatography of heparins.
    Mulloy B; Johnson EA
    Thromb Haemost; 1980 Jul; 43(3):192-3. PubMed ID: 7455984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular weight measurements of low molecular weight heparins by gel permeation chromatography.
    Mulloy B; Gee C; Wheeler SF; Wait R; Gray E; Barrowcliffe TW
    Thromb Haemost; 1997 Apr; 77(4):668-74. PubMed ID: 9134640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of low molecular weight heparins.
    Casu B; Torri G
    Semin Thromb Hemost; 1999; 25 Suppl 3():17-25. PubMed ID: 10549712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins.
    Jeske WP; Walenga JM; Hoppensteadt DA; Vandenberg C; Brubaker A; Adiguzel C; Bakhos M; Fareed J
    Semin Thromb Hemost; 2008 Feb; 34(1):74-85. PubMed ID: 18393144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in the composition of commercial heparins: comparison of anticoagulant activities and biochemical compositions of anionic density-fractionated heparins.
    Hurst RE; Settine JM; Poon MC; Lurie A
    Thromb Res; 1982 Feb; 25(3):255-65. PubMed ID: 7064135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard and method independent units for heparin anticoagulant activities.
    Hemker HC; Béguin S
    Thromb Haemost; 1993 Nov; 70(5):724-8. PubMed ID: 8128425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.